JP2018502110A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502110A5 JP2018502110A5 JP2017534789A JP2017534789A JP2018502110A5 JP 2018502110 A5 JP2018502110 A5 JP 2018502110A5 JP 2017534789 A JP2017534789 A JP 2017534789A JP 2017534789 A JP2017534789 A JP 2017534789A JP 2018502110 A5 JP2018502110 A5 JP 2018502110A5
- Authority
- JP
- Japan
- Prior art keywords
- human milk
- high fat
- composition
- kcal
- standardized high
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004251 Milk, Human Anatomy 0.000 claims 31
- 235000020256 human milk Nutrition 0.000 claims 31
- 239000000203 mixture Substances 0.000 claims 27
- 235000018102 proteins Nutrition 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 239000006071 cream Substances 0.000 claims 4
- 235000021244 human milk protein Nutrition 0.000 claims 4
- 206010006475 Bronchopulmonary dysplasia Diseases 0.000 claims 3
- 231100000533 low birth weight Toxicity 0.000 claims 1
Claims (17)
- 気管支肺異形成症（ＢＰＤ）を有するか、またはＢＰＤを発症する危険性のある乳児における１つ以上の臨床転帰の改善するためのヒト乳組成物であって、前記ヒト乳組成物が、低温殺菌ヒト乳クリーム組成物で強化されており、前記低温殺菌ヒト乳クリーム組成物が、約２．０ｋｃａｌ／ｍＬ〜約３．０ｋｃａｌ／ｍＬを含む、ヒト乳組成物。
- 前記低温殺菌ヒト乳クリーム組成物が、約２５％の脂肪および約２．５ｋｃａｌ／ｍＬを含む、請求項１に記載のヒト乳組成物。
- 前記低温殺菌ヒト乳クリーム組成物で強化したヒト乳組成物が、経腸的に投与される、請求項１に記載の方法。
- 前記改善された臨床転帰が、病院でのより短い入院期間および／または退院時におけるより早い月経後年齢である、請求項１に記載のヒト乳組成物。
- 低出生体重児における１つ以上の臨床転帰の改善するための標準化高脂肪ヒト乳組成物であって、前記標準化高脂肪ヒト乳組成物が、約１．５ｇ／１００ｋｃａｌ〜約３．０ｇ／１００ｋｃａｌのタンパク質対エネルギー比を含む、標準化高脂肪ヒト乳組成物。
- 前記標準化高脂肪ヒト乳組成物が、約１．８ｇ／１００ｋｃａｌ〜約２．８ｇ／１００ｋｃａｌのタンパク質対エネルギー比を含む、請求項５に記載の標準化高脂肪ヒト乳組成物。
- 前記標準化高脂肪ヒト乳組成物が、経腸的に投与される、請求項５に記載の標準化高脂肪ヒト乳組成物。
- 前記改善された臨床転帰が、病院でのより短い入院期間および／または退院時におけるより早い月経後年齢である、請求項５に記載の標準化高脂肪ヒト乳組成物。
- 約１．５ｇ／１００ｋｃａｌ〜約３．０ｇ／１００ｋｃａｌのエネルギー比を含む、標準化高脂肪ヒト乳組成物。
- 約１．８ｇ／１００ｋｃａｌのタンパク質対エネルギー比を含む、請求項９に記載の標準化高脂肪ヒト乳組成物。
- 約３８Ｃａｌ／ｏｚ、約２３ｍｇ／ｍＬのヒト乳タンパク質及び約９７ｍｇ／ｍＬのヒト乳脂肪を含む、請求項１０に記載の標準化高脂肪ヒト乳組成物。
- 約２．３４ｇ／１００ｋｃａｌのタンパク質対エネルギー比を含む、請求項９に記載の標準化高脂肪ヒト乳組成物。
- 約３８Ｃａｌ／ｏｚ、約３０ｍｇ／ｍＬのヒト乳タンパク質及び約９４ｍｇ／ｍＬのヒト乳脂肪を含む、請求項１２に記載の標準化高脂肪ヒト乳組成物。
- 約２．１６ｇ／１００ｋｃａｌのタンパク質対エネルギー比を含む、請求項９に記載の標準化高脂肪ヒト乳組成物。
- 約３２Ｃａｌ／ｏｚ、約２３ｍｇ／ｍＬのヒト乳タンパク質及び約７４ｍｇ／ｍＬのヒト乳脂肪を含む、請求項１４に記載の標準化高脂肪ヒト乳組成物。
- 約２．７７ｇ／１００ｋｃａｌのタンパク質対エネルギー比を含む、請求項９に記載の標準化高脂肪ヒト乳組成物。
- 約３２Ｃａｌ／ｏｚ、約３０ｍｇ／ｍＬのヒト乳タンパク質及び約７１ｍｇ／ｍＬのヒト乳脂肪を含む、請求項１６に記載の標準化高脂肪ヒト乳組成物。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098151P | 2014-12-30 | 2014-12-30 | |
| US62/098,151 | 2014-12-30 | ||
| PCT/US2015/068050 WO2016109659A1 (en) | 2014-12-30 | 2015-12-30 | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020196794A Division JP2021035993A (ja) | 2014-12-30 | 2020-11-27 | 高脂肪ヒト乳製品を使用する気管支肺異形成症の予防及び治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502110A JP2018502110A (ja) | 2018-01-25 |
| JP2018502110A5 true JP2018502110A5 (ja) | 2019-02-07 |
| JP7224760B2 JP7224760B2 (ja) | 2023-02-20 |
Family
ID=56285038
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017534789A Active JP7224760B2 (ja) | 2014-12-30 | 2015-12-30 | 高脂肪ヒト乳製品を使用する気管支肺異形成症の予防及び治療方法 |
| JP2020196794A Pending JP2021035993A (ja) | 2014-12-30 | 2020-11-27 | 高脂肪ヒト乳製品を使用する気管支肺異形成症の予防及び治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020196794A Pending JP2021035993A (ja) | 2014-12-30 | 2020-11-27 | 高脂肪ヒト乳製品を使用する気管支肺異形成症の予防及び治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170367364A1 (ja) |
| EP (1) | EP3240429A4 (ja) |
| JP (2) | JP7224760B2 (ja) |
| CN (1) | CN107249342A (ja) |
| AU (1) | AU2015374053B2 (ja) |
| CA (1) | CA2970533C (ja) |
| HK (1) | HK1245586A1 (ja) |
| WO (1) | WO2016109659A1 (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3821713A1 (en) | 2013-03-13 | 2021-05-19 | Prolacta Bioscience, Inc. | High fat human milk products |
| US11344041B2 (en) | 2015-12-30 | 2022-05-31 | Prolacta Bioscience, Inc. | Human milk products useful in pre- and post-operative care |
| KR102173673B1 (ko) * | 2018-05-04 | 2020-11-03 | 사회복지법인 삼성생명공익재단 | 기관지 폐 이형성증 (bpd) 예방 또는 치료용 물질 스크리닝 방법 |
| WO2021146561A1 (en) * | 2020-01-17 | 2021-07-22 | Prolacta Bioscience, Inc. | Feeding protocol for optimal growth of preterm infants |
| JP2022136404A (ja) | 2021-03-08 | 2022-09-21 | いすゞ自動車株式会社 | 冷却機構 |
| WO2022204463A1 (en) * | 2021-03-26 | 2022-09-29 | Prolacta Bioscience, Inc. | Methods of treatment for failure to thrive |
| AU2023229561B1 (en) * | 2023-04-13 | 2024-03-14 | Beijing Sanyuan Foods Co., Ltd. | Method for multidimensional evaluation of the similarity of samples to breast milk |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340603A (en) | 1993-08-30 | 1994-08-23 | Abbott Laboratories | Nutritional product for human infants having chronic lung disease |
| US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
| US20100268658A1 (en) | 2001-05-14 | 2010-10-21 | Prolacta Bioscience | Method for collecting, testing and distributing milk |
| MXPA04007540A (es) * | 2002-02-04 | 2004-11-10 | Squibb Bristol Myers Co | Suplemento de leche materna. |
| JP5448819B2 (ja) | 2006-08-30 | 2014-03-19 | プロラクタ バイオサイエンス，インコーポレイテッド | 無菌乳およびその組成物を得る方法 |
| DK3485742T3 (da) * | 2006-11-29 | 2021-11-15 | Prolacta Bioscience Inc | Modermælkssammensætninger og fremgangsmåder til fremstilling og anvendelse deraf |
| US8377445B2 (en) | 2006-12-08 | 2013-02-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
| RU2463810C2 (ru) * | 2007-11-26 | 2012-10-20 | Нестек С.А. | Адаптированная к возрасту система питания грудных детей |
| JP2010126495A (ja) | 2008-11-28 | 2010-06-10 | Morinaga Milk Ind Co Ltd | 母乳添加用粉末 |
| WO2011144221A1 (en) * | 2010-05-18 | 2011-11-24 | N.V. Nutricia | Preterm milk formula |
| US8563611B2 (en) * | 2011-03-17 | 2013-10-22 | Women's & Children's Health Research Institute | Methods and compositions for promoting the respiratory development of an infant |
| EP3821713A1 (en) * | 2013-03-13 | 2021-05-19 | Prolacta Bioscience, Inc. | High fat human milk products |
-
2015
- 2015-12-30 CN CN201580076878.6A patent/CN107249342A/zh active Pending
- 2015-12-30 EP EP15876253.4A patent/EP3240429A4/en active Pending
- 2015-12-30 JP JP2017534789A patent/JP7224760B2/ja active Active
- 2015-12-30 WO PCT/US2015/068050 patent/WO2016109659A1/en active Application Filing
- 2015-12-30 AU AU2015374053A patent/AU2015374053B2/en active Active
- 2015-12-30 CA CA2970533A patent/CA2970533C/en active Active
- 2015-12-30 US US15/540,937 patent/US20170367364A1/en not_active Abandoned
-
2018
- 2018-04-19 HK HK18105103.3A patent/HK1245586A1/zh unknown
-
2020
- 2020-11-27 JP JP2020196794A patent/JP2021035993A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502110A5 (ja) | ||
| Cloete | Management of severe acute malnutrition | |
| Hosokawa et al. | Balloon pulmonary angioplasty-related complications and therapeutic strategy in patients with chronic thromboembolic pulmonary hypertension | |
| Shamsiev et al. | Accompanying defects of development in children with congenital cleft of lip and palate | |
| JP2016512027A5 (ja) | ||
| Singh et al. | Role of immunity booster to manage COVID 19 pandemic | |
| McDevitt et al. | Establishing good bone health in children | |
| Reznichenko et al. | Giant primary yolk sac tumor of the liver | |
| Ramphul et al. | Children less than 2 with Down syndrome and suffering from respiratory syncytial virus have a longer and more costly hospitalization | |
| Pandey et al. | Ayurvedic management of pregnant woman infected with SARS-CoV-2–A case report | |
| Binns et al. | Infant feeding guidelines: Updating the evidence 2022 | |
| Fior et al. | A Case of Non-Hodgkin's Lymphoma. | |
| Rahbarinejad et al. | Effect of Dezful’s Day Care Center interventional program to fight malnutrition and improvement of anthropometric indices among preschool children | |
| Wakabayashi | Comment on" Early nutritional support and physiotherapy improved long-term self-sufficiency in acutely ill older patients" | |
| Kiernan et al. | Cows-feet soup: a rare cause of recurrent trichobezoar | |
| Qayumov | INTEGRATION OF FOLK AND ADDITIONAL MEDICINE INTO THE HEALTHCARE SYSTEM | |
| Monasta et al. | Breastfeeding during pregnancy: safety and socioeconomic status | |
| Lin et al. | Peristaltic waves in infantile hypertrophic pyloric stenosis | |
| Lönnerdal | Summary on Protective Factors in Human Milk | |
| Kesiak et al. | PS-267 Changes In Nutritional Management Among Very Low Birth Weight Infants Between 2010 And 2013–What We Were Be Able To Improve | |
| Leite et al. | PO-0123 The Increase In Plasma Selenium Is Independently Associated With A Better Outcome Of Children With Acute Systemic Inflammation | |
| Carnovale | Hypersensitivity skin reaction and various ADRs: case report | |
| TRUNINA et al. | Risk factors influencing on newborn survival after surgical correction of congenital heart diseases | |
| Plyusnina | MODERN APPROACHES TO THE TREATMENT OF SCHIZOPHRENIA | |
| Sandboge | Early Growth and Adult Health: Focus on Resting Metabolism, Non-Alcoholic Fatty Liver Disease, Hypertension and Regional Differences in Birth Size |